Nov 16 (Reuters) - Medipharm Labs Corp LABS.TO :
* MEDIPHARM LABS REPORTS THIRD QUARTER 2020 RESULTS
* MEDIPHARM LABS CORP QTRLY REVENUE WAS $4.9 MILLION,
COMPARED TO
$13.9 MILLION IN Q2 2020
* MEDIPHARM LABS CORP - CASH AND EQUIVALENTS BALANCE AT
SEPTEMBER
30, 2020, WAS $36.5 MILLION
* MEDIPHARM LABS CORP - ANNOUNCED DEPARTURES OF ROBERT KWON,
CFO
AND CO'S CHIEF MARKETING OFFICER
* MEDIPHARM LABS CORP - A SEARCH PROCESS HAS BEEN INITIATED
FOR A
NEW CFO
* MEDIPHARM LABS - EXPECTS REVENUE FROM PORTFOLIO OF
DOMESTIC AND
INTERNATIONAL SALES AGREEMENTS WILL GROW BEGINNING EARLY IN 2021
* MEDIPHARM LABS -DURING,SUBSEQUENT TO Q3, PRODUCTION
PROCESSES
REFINED, WORKFORCE WAS STREAMLINED BY 20% REPRESENTING $3MLN
ANNUALIZED COST REDUCTIONS
Source text for Eikon: ID:nGNX6bsZpG
Further company coverage: LABS.TO
((Reuters.Briefs@thomsonreuters.com;))